Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer
Condition(s):Breast CancerLast Updated:April 2, 2010Completed
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:April 2, 2010Completed
Condition(s):Breast CancerLast Updated:August 5, 2020Completed
Condition(s):Metastatic Breast Cancer; End of LifeLast Updated:December 7, 2023Recruiting
Condition(s):Breast CancerLast Updated:July 18, 2013Completed
Condition(s):Metastatic Breast CancerLast Updated:February 6, 2020Recruiting
Condition(s):Breast CancerLast Updated:October 19, 2020Terminated
Condition(s):Estrogen Receptor Positive; HER2/Neu Negative; Progesterone Receptor Positive; Stage IV Breast Cancer AJCC v6 and v7Last Updated:August 14, 2018Withdrawn
Condition(s):Breast CancerLast Updated:January 6, 2014Unknown status
Condition(s):Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast CancerLast Updated:March 19, 2015Terminated
Condition(s):Cardiac Toxicity; Inflammatory Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IV Breast CancerLast Updated:January 16, 2013Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.